COO & QA Manager Houman Pourhassan, PhD, has a background in immuno-oncology and drug development. Houman’s area of expertise includes multicolor flow cytometry, animal cancer models, and mammalian microbiology. In addition to high-impact scientific publications in the field of immunomodulation and nanoparticle anticancer drugs, he is experienced in industry standard GMP and PRINCE2® project management.
Associate Cecilie is BSc Eng from the Danish Technical University and currently attending the MSc programme in Biotechnology engineering.
Cecilie has broad experience in both scientific, sales and administrative areas.